Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04798781
Title Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew Hendifar, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
CS Cancer Beverly Hills Beverly Hills California 90211 United States Details
CS Cancer at The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
CS Cancer at the Samuel Oschin Cancer Center Los Angeles California 90048 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field